Member Info for RuckRover

I wouldn't bet against Covidity news on Friday. It does look like a managed release of news.

It just gets better and better.

The interviewer was only needed to make it a “proactive interview” otherwise superfluous.

Yes it does say that and, like you, I got excited but in the interview LD says going to recruit up to 108. I think it is an error in the write up.

Balerno,

I don't think they have 100 recruited, LD never said that. I think it is a mistake in the text - should be "will be" recruited.

Rigga,

I, like you have been invested for 10 years now. In 2012 I was expecting £3.20 within a year or so.
I agree with Ray's assessment:
"The general view seems to be that Scancell is just edging its way ever closer towards answering the questions we have been debating over the last 10 years."

I'd say the Moditope trial is the most significant event in the company's 26 year history. This is possibly the make or break for the company. By that I mean break would mean hovering around the current SP plus a bit but make would be a SP in £s. I'd be happy with £1 but would not sell out at the price as the potential could be much more.

You also asked...
" Personally I think we would be sitting on a least 15p now. Thoughts?"
Well TD being ultra conservative and using a RISK ADJUSTED net present value calculation AND taking into account dilution of Redmile's CLN's say 24.2p.

In my book we should be at 30p now and with some positive data 50p+

Rigga,

"So what I don't understand is why RNS of FPD on a Monday when a vast majority of our RNS are on Tuesday. Personally I think we would be sitting on a least 15p now. Thoughts?"

Although Tuesday is statistically the most likely day, it is incorrect to say the vast majority are on a Tuesday - the bias is very slight.

Bojo,

I don't think it's that strange. The real news was the trial approval. Given the fact that the trial was approved and that there are sadly many with cancer, it was inevitable that people would be dosed. Whilst this is great news for those patients, it isn't earth shattering news as the muted response today shows. The next real news will be trial data.

Cleaner,
Did you see the RNS?

Thanks Bermuda - I missed that. The value of being able to join up the dots.
Although men can get TNBC but extremely rare.

Miavoce,
How do we know it's a lady patient?

Burble,
Thanks for the reply.

A great question Konar, looking forward to Burble's reply.

Of all the risks considered, being TOO good wasn't one of them!

Burble,
Many thanks for your insights.
When you say "swathes of cancer patients" do you mean within the four targets or might these be extended? I know MODI2+ introduces additional targets but presumably these will need to go through clinical trials of their own. If the MODI1 targets can be expanded, this may be a quicker way to get treatments approved.

tick-tock

Violin,
I think I hit the wall as well - give me a shove when you pass me.

Hopefully not a mis-kick either.

Iofas,
"“Normally a CEO selling a significant amount of shares would be a red flag and negatively impact the SP”
It was negative enough sliding from almost 50 percent."

Let's try a few facts......

The closing SP on the day of the announcement (09/09/2021) was 22.25p
The closing SP yesterday was 12.25p - that is a 45% drop
Was this down to the CEO selling?
No. The SP on the day of announcement was 22.25p and it remained around that for over a month - 22.5p on 14/10/2021. It remained above 20p until 21/01/2022. Since then it has slid to where we are today (four months after the CEO sale)

Apologies to those who find actual facts uncomfortable.

xviolet,

Back in September Lindy Durrant CEO "sold" 6,840,633 shares. Normally a CEO selling a significant amount of shares would be a red flag and negatively impact the SP.
However, it wasn't a straightforward "sell" but rather a rejig of her package involving transfer of shares from the Scancell Employee Benefit Trust and the award of a further 9 million share options.
The sale was in two tranches:
4,459,681 Shares at 20.38p pence per share to an existing institutional investor (Redmile)
2,380,952 shares at 21 pence per share to "a private individual"

There has been some speculation as to who the private individual was. (It turns out it was actually a "private individual")

Is there anything we can draw from this?

1. Lindy Durrant is (quite rightly) highly regarded by our biggest investor and seen key to success.
2. Redmile were quite happy to stump up 20p per share so don't worry that we are currently at 12p
3. A private individual was happy to stump up 21p per share (ditto)
4. With 9 miliion share options LD has plenty of incetive a) to succeed and b) secure the best possible price.

AB,
To bastardise something, for example a post, would be to twist it and degrade its value.
The accusation is that you have bastardised posters which means you have declared certain posters "bastards". I don't recall you doing that ever so I suspect it is just an unfortunate typo and/or predictive text. I'm sure C7 will clarify once he realises it.